Faculty who have authored publication Sequencing of novel agents in relapsed/refractory B-cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemia.
| Name | Title | Department | Institution |
|---|---|---|---|
| Ehab L. Atallah MD | Professor | Medicine | Medical College of Wisconsin |
| Aniko Szabo PhD | Professor | Institute for Health and Equity | Medical College of Wisconsin |
